Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AV75
Term | Name | Level | Count |
---|---|---|---|
GO:0002161 | aminoacyl-tRNA editing activity | 5 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 12 |
GO:0052689 | carboxylic ester hydrolase activity | 4 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
GO:0004812 | aminoacyl-tRNA ligase activity | 4 | 2 |
GO:0016874 | ligase activity | 2 | 2 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 3 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 113 | 115 | PF00675 | 0.353 |
CLV_NRD_NRD_1 | 85 | 87 | PF00675 | 0.440 |
CLV_PCSK_KEX2_1 | 113 | 115 | PF00082 | 0.353 |
CLV_PCSK_KEX2_1 | 18 | 20 | PF00082 | 0.447 |
CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.491 |
CLV_PCSK_PC1ET2_1 | 18 | 20 | PF00082 | 0.411 |
CLV_PCSK_SKI1_1 | 114 | 118 | PF00082 | 0.370 |
CLV_PCSK_SKI1_1 | 127 | 131 | PF00082 | 0.228 |
DEG_SCF_TRCP1_1 | 90 | 96 | PF00400 | 0.361 |
DOC_CYCLIN_yCln2_LP_2 | 185 | 191 | PF00134 | 0.483 |
DOC_CYCLIN_yCln2_LP_2 | 222 | 228 | PF00134 | 0.483 |
DOC_PP2B_LxvP_1 | 117 | 120 | PF13499 | 0.294 |
DOC_PP2B_LxvP_1 | 222 | 225 | PF13499 | 0.462 |
DOC_SPAK_OSR1_1 | 19 | 23 | PF12202 | 0.416 |
DOC_USP7_MATH_1 | 4 | 8 | PF00917 | 0.584 |
DOC_USP7_MATH_1 | 48 | 52 | PF00917 | 0.690 |
LIG_14-3-3_CanoR_1 | 247 | 255 | PF00244 | 0.224 |
LIG_Actin_WH2_2 | 23 | 39 | PF00022 | 0.521 |
LIG_BRCT_BRCA1_1 | 94 | 98 | PF00533 | 0.313 |
LIG_CSL_BTD_1 | 99 | 102 | PF09270 | 0.421 |
LIG_FHA_2 | 135 | 141 | PF00498 | 0.474 |
LIG_FHA_2 | 259 | 265 | PF00498 | 0.487 |
LIG_LIR_Gen_1 | 147 | 157 | PF02991 | 0.462 |
LIG_LIR_Gen_1 | 242 | 253 | PF02991 | 0.493 |
LIG_LIR_Gen_1 | 95 | 106 | PF02991 | 0.481 |
LIG_LIR_Nem_3 | 147 | 153 | PF02991 | 0.462 |
LIG_LIR_Nem_3 | 242 | 248 | PF02991 | 0.460 |
LIG_LIR_Nem_3 | 95 | 101 | PF02991 | 0.328 |
LIG_SH2_SRC | 154 | 157 | PF00017 | 0.472 |
LIG_SH2_STAT5 | 150 | 153 | PF00017 | 0.465 |
LIG_SH2_STAT5 | 156 | 159 | PF00017 | 0.465 |
LIG_SH2_STAT5 | 228 | 231 | PF00017 | 0.507 |
LIG_SH3_3 | 59 | 65 | PF00018 | 0.594 |
LIG_SH3_3 | 72 | 78 | PF00018 | 0.580 |
LIG_SUMO_SIM_par_1 | 211 | 216 | PF11976 | 0.443 |
LIG_TRAF2_1 | 168 | 171 | PF00917 | 0.457 |
LIG_TRAF2_1 | 261 | 264 | PF00917 | 0.386 |
LIG_TYR_ITIM | 152 | 157 | PF00017 | 0.539 |
MOD_CK1_1 | 51 | 57 | PF00069 | 0.676 |
MOD_CK2_1 | 258 | 264 | PF00069 | 0.411 |
MOD_CK2_1 | 4 | 10 | PF00069 | 0.431 |
MOD_Cter_Amidation | 176 | 179 | PF01082 | 0.237 |
MOD_GlcNHglycan | 198 | 201 | PF01048 | 0.329 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.414 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.640 |
MOD_GlcNHglycan | 67 | 71 | PF01048 | 0.493 |
MOD_GlcNHglycan | 90 | 93 | PF01048 | 0.396 |
MOD_GSK3_1 | 192 | 199 | PF00069 | 0.500 |
MOD_GSK3_1 | 213 | 220 | PF00069 | 0.505 |
MOD_GSK3_1 | 254 | 261 | PF00069 | 0.354 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.681 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.300 |
MOD_N-GLC_1 | 144 | 149 | PF02516 | 0.257 |
MOD_NEK2_1 | 125 | 130 | PF00069 | 0.437 |
MOD_NEK2_1 | 131 | 136 | PF00069 | 0.438 |
MOD_PIKK_1 | 217 | 223 | PF00454 | 0.450 |
MOD_PKA_2 | 192 | 198 | PF00069 | 0.396 |
MOD_PKA_2 | 246 | 252 | PF00069 | 0.529 |
MOD_Plk_1 | 144 | 150 | PF00069 | 0.432 |
MOD_Plk_1 | 51 | 57 | PF00069 | 0.676 |
MOD_Plk_1 | 66 | 72 | PF00069 | 0.643 |
MOD_Plk_4 | 125 | 131 | PF00069 | 0.444 |
MOD_SUMO_rev_2 | 69 | 78 | PF00179 | 0.396 |
TRG_ENDOCYTIC_2 | 149 | 152 | PF00928 | 0.465 |
TRG_ENDOCYTIC_2 | 154 | 157 | PF00928 | 0.465 |
TRG_ER_diArg_1 | 112 | 114 | PF00400 | 0.346 |
TRG_ER_diArg_1 | 84 | 86 | PF00400 | 0.446 |
TRG_NES_CRM1_1 | 11 | 24 | PF08389 | 0.422 |
TRG_Pf-PMV_PEXEL_1 | 167 | 171 | PF00026 | 0.309 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I030 | Leptomonas seymouri | 73% | 100% |
A0A0S4IHR6 | Bodo saltans | 48% | 100% |
A0A1X0NXR2 | Trypanosomatidae | 49% | 100% |
A0A3Q8IDY4 | Leishmania donovani | 88% | 99% |
A0A422NWD3 | Trypanosoma rangeli | 49% | 100% |
A4HK97 | Leishmania braziliensis | 80% | 100% |
D0A1C2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 100% |
E9AGV9 | Leishmania infantum | 89% | 71% |
Q4QCA6 | Leishmania major | 90% | 100% |
V5B6I0 | Trypanosoma cruzi | 50% | 100% |